Severe eosinophilic asthma: remission with add-on therapy with benralizumab

被引：0
|
作者：
Hofmann-Assmus, Marion
机构：
来源：
ALLERGO JOURNAL | 2023年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia
    Jefferson Antonio, Buendia
    Patino, Diana Guerrero
    Lopez Moreno, Melisa
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (02) : 299 - 305
  • [2] ECONOMIC EVALUATION OF BENRALIZUMAB AS ADD-ON MAINTENANCE TREATMENT OF ADULT PATIENTS IN MEXICO WITH UNCONTROLLED SEVERE EOSINOPHILIC ASTHMA
    Buritica, M. P.
    Carmona Marin, M.
    Barriga, V
    Guzman, J.
    Carlos, F.
    [J]. VALUE IN HEALTH, 2020, 23 : S352 - S352
  • [3] Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype
    Al Efraij, Khalid
    FitzGerald, J. Mark
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (07) : 669 - 676
  • [4] Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
    Yancey, Steven W.
    Ortega, Hector G.
    Keene, Oliver N.
    Bradford, Eric S.
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2019, 15 (01):
  • [5] Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
    Steven W. Yancey
    Hector G. Ortega
    Oliver N. Keene
    Eric S. Bradford
    [J]. Allergy, Asthma & Clinical Immunology, 15
  • [6] Nucala Approved as Add-On Treatment for Severe Asthma With Eosinophilic Inflammation
    不详
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2015, 21 (12): : 42 - 45
  • [7] BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AS AN ADD-ON THERAPY IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE
    Abbott, T.
    Balmaceda, C.
    Espinoza, M. A.
    [J]. VALUE IN HEALTH, 2020, 23 : S15 - S15
  • [8] Benralizumab (Fasenra) for Severe Eosinophilic Asthma
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1541): : 33 - 35
  • [9] Effect of add-on therapies (mepolizumab, omalizumab or azithromycin) on asthma remission in severe asthma
    Thomas, Dennis
    Mcdonald, Vanessa
    Stevens, Sean
    Harvey, Erin
    Baraket, Melissa
    Bardin, Philip
    Bowden, Jeff
    Bowler, Simon
    Chien, Jimmy
    Chung, Li Ping
    Gillman, Andrew
    Hew, Mark
    Hodge, Sandra
    James, Alan
    Jenkins, Christine
    Katelaris, Constance
    Katsoulotos, Gregory
    Langton, David
    Lee, Joy
    Marks, Guy
    Peters, Matthew
    Radhakrishna, Naghmeh
    Reynolds, Paul
    Rimmer, Janet
    Sivakumaran, Pathmanathan
    Upham, John
    Wark, Peter
    Yang, Ian
    Gibson, Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use
    Maselli, Diego Jose
    Rogers, Linda
    Peters, Jay I.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 2059 - 2068
12345